U.S. lawyers Baum, Hedlund, Aristei & Goldman have been representing antidepressant victims for almost two decades in high-profile cases against major pharma companies like GSK, Pfizer and Eli Lilly, challenging antidepressant efficacy and safety. Their litigation success and advocacy efforts in this field are the subject of numerous articles, news stories, documentaries, books and blogs. They have backed congressional movements toward more aggressive drug safety, not only in the U.S., but European and Asian countries as well. Given their extensive experience in investigating drug company wrongdoing, they now also represent whistleblowers of pharmaceutical fraud.
Get in touch - Click on the banner.
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
No comments: